CN102772472A - Tincture medicine for treating verruca vulgaris - Google Patents
Tincture medicine for treating verruca vulgaris Download PDFInfo
- Publication number
- CN102772472A CN102772472A CN2012102113522A CN201210211352A CN102772472A CN 102772472 A CN102772472 A CN 102772472A CN 2012102113522 A CN2012102113522 A CN 2012102113522A CN 201210211352 A CN201210211352 A CN 201210211352A CN 102772472 A CN102772472 A CN 102772472A
- Authority
- CN
- China
- Prior art keywords
- verruca vulgaris
- medicine
- treating verruca
- treating
- tincture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to a Chinese herba preparation, in particular to a tincture medicine for treating verruca vulgaris. The tincture medicine for treating verruca vulgaris is prepared by the following raw materials: 20-25 g of Brucea javanica, 20-25 g of moleplant seed, 20-25 g of Euroleon sinicus, 2-3 centipedes and 500-600 ml of 75% alcohol. The tincture medicine for treating verruca vulgaris has the advantages of being novel in raw material formula, simple to prepare, convenient to use, fast in absorption and good in effect.
Description
Technical field:
The present invention relates to a kind of Chinese medicine preparation, promptly a kind of tincture dose medicament of treating verruca vulgaris.
Background technology:
Verruca vulgaris is meant by the caused epiderm skin graininess of cardinal principle human papillomavirus neoplasm.Its symptom shows as: originally be big or small, smooth, shinny, the translucent flat erythra of syringe needle to increase to the Semen Pisi sativi shape gradually, rough surface is uneven, gray or yellowish-brown.At present, the medicine of state's internal therapy verruca vulgaris is more, is main with Western medicine mainly, also uses laser therapy, but has shortcomings such as medical expense is high, therapeutic effect is satisfied inadequately.
Summary of the invention:
The objective of the invention is to make the existing weak point of medicament, and a kind of tincture dose medicament of treating verruca vulgaris is provided to treating verruca vulgaris at present.
Technical scheme of the present invention is achieved in that
A kind of tincture dose medicament of treating verruca vulgaris, this medicine is processed by following raw material: Fructus Bruceae, Semen Euphorbiae, each 20-25 gram of Myrmeleonmicans Mac Lachlan, Scolopendra 2-3 bar, 75% ethanol 500-600 milliliter.
A kind of tincture dose medicament of treating verruca vulgaris, the method for preparing of this medicine is: earlier 4 flavors before the said ratio amount raw material of Chinese medicine are dried the fine powder that was ground into 80 mesh sieves, mix homogeneously; Pack in the vial; Add proportional quantity ethanol then, the capped sealing was soaked 10 days; Get the supernatant, tincture dose medicament.
A kind of tincture dose medicament of treating verruca vulgaris, the pharmaceutical formulation cost of material is cheap, gets material easily, can reduce medical expense, alleviates patient economy burden.
A kind of tincture dose medicament of treating verruca vulgaris, its treatment thinking is counteracting toxic substances dampness, drastically removing blood stasis and resolving static blood.On composition of raw materials, follow the property of medicine through belonging to, lay particular stress on counteracting toxic substances dampness, take into account whole machine balancing.Fructus Bruceae has heat clearing and damp drying, parasite killing Detoxication in the medicine, and Semen Euphorbiae has the detumescence of relieving oedema or abdominal distension through diuresis or purgation, removing blood stasis with potent drugs insecticidal action, and Myrmeleonmicans Mac Lachlan has the effect of counteracting toxic substances removing blood stasis, and Scolopendra has the dispersing pathogen accumulation effect, and ethanol has promoting blood circulation, the effect of row medicine gesture.Above-mentioned raw material of Chinese medicine is through dialectical compatibility, complements each other using, and especially medicine directly invested focus, thereby given play to the effect of counteracting toxic substances dampness, drastically removing blood stasis and resolving static blood effectively, to reach the purpose of curing verruca vulgaris.
The present invention has following characteristics: composition of raw materials is novel, preparation is simple, easy to use, it is fast, effective to absorb.
Method for using:
1, this medicine is a medicine for external application.
2, consumption: every day 4-5 time, whenever carried out once at a distance from 2 hours.
3, method: dip in tincture dose medicament with absorbent liquor ball and be coated with and put the affected part on the skin, be coated with back and forth at every turn and put 8-10 time on the skin.
Points for attention:
1, during the treatment, avoids eating anything raw or cold, pungent, greasy, irritant food.
2, forbid taking orally.
The specific embodiment:
Embodiment 1: a kind of material combination of treating the tincture dose medicament of verruca vulgaris is: Fructus Bruceae, Semen Euphorbiae, each 20 gram of Myrmeleonmicans Mac Lachlan, 2 of Scolopendras, 500 milliliters of 75% ethanol.The method for preparing of this medicine is: earlier 4 flavors before the said ratio amount raw material of Chinese medicine are dried the fine powder that was ground into 80 mesh sieves, mix homogeneously is in the vial of packing into; Add proportional quantity ethanol then, the capped sealing was soaked 10 days; Get the supernatant, tincture dose medicament.
Embodiment 2: a kind of material combination of treating the tincture dose medicament of verruca vulgaris is: Fructus Bruceae, Semen Euphorbiae, each 25 gram of Myrmeleonmicans Mac Lachlan, 3 of Scolopendras, 600 milliliters of 75% ethanol.The method for preparing of this medicine is: earlier 4 flavors before the said ratio amount raw material of Chinese medicine are dried the fine powder that was ground into 80 mesh sieves, mix homogeneously is in the vial of packing into; Add proportional quantity ethanol then, the capped sealing was soaked 10 days; Get the supernatant, tincture dose medicament.
Clinical therapeutic efficacy:
Experimentation: 2006 to 2011, adopt this technical scheme treatment verruca vulgaris patient totally 12 examples, male's 10 examples wherein, women's 2 examples.Minimum 10 years old of patient age, maximum 57 years old, wherein 30-50 year patient 7 examples accounted for 584%.The shortest person of sick time 20 days, elder 3 years, wherein 7 routine sick times at 20 days between half a year.By the technique scheme treatment, 10 days is a course of treatment, treats promptly to stop two courses of treatment.
Diagnostic criteria: a kind of tincture dose medicament of treating verruca vulgaris, the disease of being treated, its symptom is confirmed as: originally be big or small, smooth, shinny, the translucent flat erythra of syringe needle to increase to the Semen Pisi sativi shape gradually, rough surface is uneven, gray or yellowish-brown.
Curative effect judging standard: curative effect judges that whether mainly be dependent on this disease symptoms disappears, and specifically is divided into following three grades: recovery from illness---after patient's medication, and all symptom complete obiterations of disease; Taking a turn for the better---after patient's medication, all symptom major parts of disease disappear or obviously alleviate; Invalid---after patient's medication, all symptoms of disease have no to disappear.
Therapeutic outcome: with Drug therapy verruca vulgaris patient 12 examples of the present invention, medication 8 days recovery from illness 1 example, medication recovery from illness in 10 days 3 examples, medication 11-20 days 4 examples of fully recovering, medication 4 examples that take a turn for the better after two courses of treatment.Cure rate is that cure rate is 66% in 33%, two course of treatment in one course of treatment, and effective percentage is 100%.Wherein sick time 20 days to 7 routine patients between half a year, 6 example recoveries from illness after medication two courses of treatment, 1 example obviously reduces in addition; The 5 routine patients that ill half a year is above, 2 example recoveries from illness after medication two courses of treatment, 3 routine symptoms are most of in addition disappears.Analyze thus, medicine of the present invention is better than the longer patient of the course of disease to the shorter patient treatment effect of the course of disease.
Claims (1)
1. tincture dose medicament of treating verruca vulgaris is characterized in that this medicine processed by following raw material: Fructus Bruceae, Semen Euphorbiae, each 20-25 gram of Myrmeleonmicans Mac Lachlan, Scolopendra 2-3 bar, 75% ethanol 500-600 milliliter.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012102113522A CN102772472A (en) | 2012-06-15 | 2012-06-15 | Tincture medicine for treating verruca vulgaris |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012102113522A CN102772472A (en) | 2012-06-15 | 2012-06-15 | Tincture medicine for treating verruca vulgaris |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102772472A true CN102772472A (en) | 2012-11-14 |
Family
ID=47117729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012102113522A Pending CN102772472A (en) | 2012-06-15 | 2012-06-15 | Tincture medicine for treating verruca vulgaris |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102772472A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103961624A (en) * | 2014-05-14 | 2014-08-06 | 马鞍山科信咨询有限公司 | External traditional Chinese medicine for treating verruca vulgaris |
| CN106668076A (en) * | 2017-01-23 | 2017-05-17 | 黄虓鹏 | Anti-cancer medicinal liquor as well as preparation method and application thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060257509A1 (en) * | 2003-10-10 | 2006-11-16 | Zimmerman Amy C | Cosmetic composition and methods |
| CN1899520A (en) * | 2006-06-26 | 2007-01-24 | 刘兆运 | Chinese medicine composition for removing wart nevus |
| CN101199785A (en) * | 2007-12-13 | 2008-06-18 | 骆金根 | Tincture medicament for treating common wart |
-
2012
- 2012-06-15 CN CN2012102113522A patent/CN102772472A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060257509A1 (en) * | 2003-10-10 | 2006-11-16 | Zimmerman Amy C | Cosmetic composition and methods |
| CN1899520A (en) * | 2006-06-26 | 2007-01-24 | 刘兆运 | Chinese medicine composition for removing wart nevus |
| CN101199785A (en) * | 2007-12-13 | 2008-06-18 | 骆金根 | Tincture medicament for treating common wart |
Non-Patent Citations (4)
| Title |
|---|
| 刘忠恕: "《现代中医皮肤病学》", 31 August 1997, 天津科技翻译出版公司 * |
| 张兆旺: "《中药药剂学》", 31 January 2003, 中国中医药出版社 * |
| 李膺: ""化疣散"治扁平疣及传染软疣", 《医学理论与实践》 * |
| 王善儒: "疣速净治疗尿道尖锐湿疣2例", 《中国皮肤性病学杂志》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103961624A (en) * | 2014-05-14 | 2014-08-06 | 马鞍山科信咨询有限公司 | External traditional Chinese medicine for treating verruca vulgaris |
| CN106668076A (en) * | 2017-01-23 | 2017-05-17 | 黄虓鹏 | Anti-cancer medicinal liquor as well as preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102772472A (en) | Tincture medicine for treating verruca vulgaris | |
| CN103479737A (en) | Traditional Chinese medicine composition for treating senile cutaneous pruritus and application thereof | |
| CN102772505B (en) | A kind of oil preparation medicine for the treatment of impetigo | |
| CN102784194A (en) | Oil solution medicament for treating scald | |
| CN102846861A (en) | Tincture medicament for treating local pruritus cutanea | |
| CN101919909A (en) | Externally applied medicine for treating tinea capitis | |
| CN102755453B (en) | A kind of fumigation-washing medicine treating chronic eczema of scrotum | |
| CN102764289A (en) | Externally applied medicine for treating single poisonous wasp sting | |
| CN102872196A (en) | Tincture medicament for treating wet beriberi | |
| CN102743449A (en) | Powder medicament for treating thrush | |
| CN102772539B (en) | A kind of tincture dose medicament for the treatment of asthenic cold type nasal polyp | |
| CN102755548A (en) | Powder medicine for curing acute eczema scroti | |
| CN102784291B (en) | A kind of liniment for the treatment of toothache with asthenic yin | |
| CN102784201B (en) | A kind of caking for the treatment of is without the pasty medicament of head dummy summer boil | |
| CN102772470A (en) | External-application medicine for treating lung-heat rhinopolypus | |
| CN102764312B (en) | A kind of Wash-out medicine for the treatment of scabies | |
| CN102319293A (en) | Traditional Chinese medicine preparation for treating psoriasis | |
| CN102895346A (en) | Fumigating medicament for treating conjunctivitis | |
| CN102861188A (en) | Tincture medicament for treating scabies | |
| CN102846724A (en) | Tincture medicament for treating blood-dryness-type psoriasis | |
| CN103505697A (en) | Medicine used for treating orthopaedic diseases, and preparation method thereof | |
| CN102764291A (en) | Tincture medicine for treating tinea versicolor | |
| CN102764354A (en) | Externally applied medicine for treating impetigo | |
| CN102784239A (en) | Orally-administrated medicinal tea bag for treating chronic tonsillitis | |
| CN102764276A (en) | Medicinal cataplasm for treating tinea versicolor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20121114 |
|
| RJ01 | Rejection of invention patent application after publication |